At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- When GI Puts AI to Work Beyond Polyp Detection
- AI Model Detects Colorectal Cancer and Advanced Adenomas in Blood (Bioengineer)
- ACG: Anesthesia support, strategic integration of APPs needed to bolster GI workforce (Healio)
- Medicare adds specialty code for physician nutrition specialists (GI & Hepatology News)
- EnVision Endoscopy Announces Oversubscribed Series A Financing and Reaches First 50 Patient Procedures with SimpleStitch™ Suturing System (PR Newswire)
- GI centers can’t explain their cancellation spike (Becker’s GI & Endoscopy)
- Beyond Burnout: Recognizing and Reframing the Heartsink Response in Gastroenterologists and Hepatologists (Gastroenterology)
- AGA and AASLD Joint Guidelines on PBC Diagnosis and Management (Gastroenterology Advisor)
